Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	224.25	128.1	54.91	346.07	41.7
Short-Term Investments	147.9	104.31	207.91	-	-
Cash & Short-Term Investments	372.15	232.41	262.83	346.07	41.7
Cash Growth	60.12%	-11.57%	-24.05%	729.93%	595.56%
Other Receivables	0.17	0.51	7.66	-	0.1
Receivables	0.17	0.51	7.66	-	0.1
Prepaid Expenses	5.12	3.29	4.44	2.6	1.79
Restricted Cash	-	-	0.96	-	-
Total Current Assets	377.44	236.21	275.89	348.67	43.59
Property, Plant & Equipment	56.31	62.61	61.91	12.33	4.62
Other Long-Term Assets	4.98	4.93	4.6	5.34	1.16
Total Assets	438.73	303.76	342.39	366.33	49.38
Accounts Payable	17.22	11.15	7.86	6.56	7.07
Accrued Expenses	15.43	12.93	9.56	9.24	1.13
Current Portion of Leases	3.71	3.16	3.13	-	-
Current Unearned Revenue	117.23	17.68	-	-	-
Other Current Liabilities	3.35	1.67	5.02	0.84	21.08
Total Current Liabilities	156.95	46.59	25.57	16.64	29.28
Long-Term Leases	39	42.88	43.87	-	-
Long-Term Unearned Revenue	16.15	32.32	-	-	-
Total Liabilities	215.8	124.51	70.98	18.81	30.34
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	664.87	547.86	503.7	471.57	0.4
Retained Earnings	-438.59	-365.89	-230.54	-122.04	-48.08
Comprehensive Income & Other	-3.36	-2.72	-1.75	-2.02	-1.06
Total Common Equity	222.94	179.25	271.41	347.52	-48.73
Shareholders' Equity	222.94	179.25	271.41	347.52	19.04
Total Liabilities & Equity	438.73	303.76	342.39	366.33	49.38
Total Debt	42.72	46.04	47	-	-
Net Cash (Debt)	329.43	186.37	215.83	346.07	41.7
Net Cash Growth	76.76%	-13.65%	-37.64%	729.93%	695.02%
Net Cash Per Share	4.46	3.63	4.57	13.84	27.49
Filing Date Shares Outstanding	61.51	50.14	49.24	46.37	1.69
Total Common Shares Outstanding	61.51	50.14	49.32	46.54	1.69
Working Capital	220.49	189.62	250.32	332.03	14.32
Book Value Per Share	3.62	3.57	5.50	7.47	-28.91
Tangible Book Value	222.94	179.25	271.41	347.52	-48.73
Tangible Book Value Per Share	3.62	3.57	5.50	7.47	-28.91
Machinery	27.4	24.23	18.65	13.06	5.23
Construction In Progress	0.06	0.92	12.01	0.85	-
Leasehold Improvements	22.39	20.89	2.66	1.12	-

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q